Back
ClearPoint Neuro Vs. Asensus Surgical Industry Stock Comparison
Sell
23
CLPT
ClearPoint Neuro
Last Price:
5.43
Seasonality Move:
-7.24%
Sell
29
ASXC
Asensus Surgical
Last Price:
0.24
Seasonality Move:
10.66%
Sell
23
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy, Sell or Hold?
- The current ClearPoint Neuro [CLPT] share price is $5.45. The Score for CLPT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CLPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Asensus Surgical (ASXC)
is a Sell
Is Asensus Surgical a Buy, Sell or Hold?
- The current Asensus Surgical [ASXC] share price is $0.25. The Score for ASXC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ASXC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLPT Stock Price Chart
What is ClearPoint Neuro's stock price today?
-
The ClearPoint Neuro share price today is $5.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASXC Stock Price Chart
What is Asensus Surgical's stock price today?
-
The Asensus Surgical share price today is $0.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASXC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 37.46 | Sell |
| Chaikin Money Flow: | 34403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.41 - 6.47) | Sell |
| Bollinger Bands (100): | (6.02 - 7.32) | Sell |
ASXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.08 | Sell |
| Chaikin Money Flow: | -71847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.23 - 0.27) | Sell |
| Bollinger Bands (100): | (0.25 - 0.31) | Sell |
CLPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.38 | Buy |
| 20-day SMA: | 5.77 | Sell |
| 50-day SMA: | 6.4 | Sell |
| 200-day SMA: | 6.13 | Sell |
| 8-day EMA: | 5.42 | Buy |
| 20-day EMA: | 5.72 | Sell |
| 50-day EMA: | 6.18 | Sell |
| 200-day EMA: | 6.64 | Sell |
ASXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.25 | Sell |
| 20-day SMA: | 0.26 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.26 | Sell |
| 50-day EMA: | 0.27 | Sell |
| 200-day EMA: | 0.32 | Sell |
ClearPoint Neuro Earnings Growth & CLPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.05 per share.
Asensus Surgical Earnings Growth & ASXC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.12 per share, and an increase next year of $0.06 per share.
ClearPoint Neuro Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Asensus Surgical Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||